229 related articles for article (PubMed ID: 20824099)
1. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
3. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
Singh M; Krajewski M; Mikolajka A; Holak TA
J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
[TBL] [Abstract][Full Text] [Related]
6. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
Patrick DR; Oliff A; Heimbrook DC
J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
10. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
11. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
Gulliver GA; Herber RL; Liem A; Lambert PF
J Virol; 1997 Aug; 71(8):5905-14. PubMed ID: 9223480
[TBL] [Abstract][Full Text] [Related]
12. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
14. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
[TBL] [Abstract][Full Text] [Related]
15. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
Zhang B; Chen W; Roman A
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
[TBL] [Abstract][Full Text] [Related]
16. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
Rabachini T; Boccardo E; Andrade R; Perez KR; Nonogaki S; Cuccovia IM; Villa LL
BMC Cancer; 2018 Apr; 18(1):485. PubMed ID: 29703186
[TBL] [Abstract][Full Text] [Related]
17. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins.
Dick FA; Dyson NJ
J Virol; 2002 Jun; 76(12):6224-34. PubMed ID: 12021356
[TBL] [Abstract][Full Text] [Related]
18. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
Nor Rashid N; Yusof R; Watson RJ
Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
[TBL] [Abstract][Full Text] [Related]
19. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
20. A humanized mouse model of HPV-associated pathology driven by E7 expression.
Buitrago-Pérez Á; Hachimi M; Dueñas M; Lloveras B; Santos A; Holguín A; Duarte B; Santiago JL; Akgül B; Rodríguez-Peralto JL; Storey A; Ribas C; Larcher F; del Rio M; Paramio JM; García-Escudero R
PLoS One; 2012; 7(7):e41743. PubMed ID: 22911850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
